Legacy Wealth Asset Management LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,036 shares of the semiconductor company’s stock, valued at approximately $1,498,000.
A number of other hedge funds have also added to or reduced their stakes in SNPS. Independence Bank of Kentucky grew its position in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares during the period. Saudi Central Bank acquired a new position in shares of Synopsys during the 1st quarter valued at $26,000. Princeton Global Asset Management LLC boosted its stake in Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after acquiring an additional 53 shares in the last quarter. AlphaQuest LLC grew its holdings in Synopsys by 423.1% in the second quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 55 shares during the period. Finally, WPG Advisers LLC bought a new stake in Synopsys in the first quarter valued at $34,000. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Up 1.2%
SNPS stock opened at $463.73 on Monday. The firm has a market capitalization of $86.14 billion, a PE ratio of 58.04, a P/E/G ratio of 3.86 and a beta of 1.16. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The stock’s 50 day moving average is $434.19 and its 200-day moving average is $504.21.
Wall Street Analysts Forecast Growth
SNPS has been the topic of a number of research analyst reports. The Goldman Sachs Group cut their price objective on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. KeyCorp increased their price target on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Needham & Company LLC raised their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. BNP Paribas began coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price on the stock. Finally, Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Eleven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and a consensus price target of $562.13.
Get Our Latest Analysis on SNPS
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: KeyCorp reiterated bullish coverage and published multi?year EPS projections and a $600 price target, which supports upside expectations for SNPS and likely helped buying interest. KeyCorp estimates and MarketBeat summary
- Neutral Sentiment: Zacks and other outlets note elevated investor attention in SNPS; increased retail/institutional focus can amplify moves in either direction but does not by itself change fundamentals. Zacks: Investor Attention
- Neutral Sentiment: MarketWatch flagged that SNPS underperformed peers on a relative basis despite daily gains — a reminder that sector rotation and peer performance are constraining factors. MarketWatch: Relative Performance
- Negative Sentiment: Multiple securities?fraud class?action notices and law?firm solicitations have been filed or distributed, alleging material misstatements for purchases made between Dec. 4, 2024 and Sept. 9, 2025; the widely publicized Dec. 30, 2025 lead?plaintiff deadline increases headline risk and potential legal exposure. GlobeNewswire: Class Action Filed
- Negative Sentiment: Several plaintiff firms (Rosen, Levi & Korsinsky, Faruqi & Faruqi, Bleichmar Fonti & Auld, Schall, Gross, etc.) are soliciting lead?plaintiff applications — this broad outreach typically precedes contested litigation phases that can drive volatility and potentially settlement costs or reputational damage. Example notice: Rosen Law Firm: Final Deadline Notice
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Wall Street Stock picker Names #1 Stock of 2026
- End of America update
- They Laughed at $30. They Won’t Laugh at $70.
- The McDonald’s Secret
- How Long Will $1M Last in Retirement?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
